Cargando…
Modelling renal defects in Bardet-Biedl syndrome patients using human iPS cells
Bardet-Biedl syndrome (BBS) is a ciliopathy with pleiotropic effects on multiple tissues, including the kidney. Here we have compared renal differentiation of iPS cells from healthy and BBS donors. High content image analysis of WT1-expressing kidney progenitors showed that cell proliferation, diffe...
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10272764/ https://www.ncbi.nlm.nih.gov/pubmed/37333983 http://dx.doi.org/10.3389/fcell.2023.1163825 |
_version_ | 1785059569357029376 |
---|---|
author | Williams, James Hurling, Chloe Munir, Sabrina Harley, Peter Machado, Carolina Barcellos Cujba, Ana-Maria Alvarez-Fallas, Mario Danovi, Davide Lieberam, Ivo Sancho, Rocio Beales, Philip Watt, Fiona M. |
author_facet | Williams, James Hurling, Chloe Munir, Sabrina Harley, Peter Machado, Carolina Barcellos Cujba, Ana-Maria Alvarez-Fallas, Mario Danovi, Davide Lieberam, Ivo Sancho, Rocio Beales, Philip Watt, Fiona M. |
author_sort | Williams, James |
collection | PubMed |
description | Bardet-Biedl syndrome (BBS) is a ciliopathy with pleiotropic effects on multiple tissues, including the kidney. Here we have compared renal differentiation of iPS cells from healthy and BBS donors. High content image analysis of WT1-expressing kidney progenitors showed that cell proliferation, differentiation and cell shape were similar in healthy, BBS1, BBS2, and BBS10 mutant lines. We then examined three patient lines with BBS10 mutations in a 3D kidney organoid system. The line with the most deleterious mutation, with low BBS10 expression, expressed kidney marker genes but failed to generate 3D organoids. The other two patient lines expressed near normal levels of BBS10 mRNA and generated multiple kidney lineages within organoids when examined at day 20 of organoid differentiation. However, on prolonged culture (day 27) the proximal tubule compartment degenerated. Introducing wild type BBS10 into the most severely affected patient line restored organoid formation, whereas CRISPR-mediated generation of a truncating BBS10 mutation in a healthy line resulted in failure to generate organoids. Our findings provide a basis for further mechanistic studies of the role of BBS10 in the kidney. |
format | Online Article Text |
id | pubmed-10272764 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-102727642023-06-17 Modelling renal defects in Bardet-Biedl syndrome patients using human iPS cells Williams, James Hurling, Chloe Munir, Sabrina Harley, Peter Machado, Carolina Barcellos Cujba, Ana-Maria Alvarez-Fallas, Mario Danovi, Davide Lieberam, Ivo Sancho, Rocio Beales, Philip Watt, Fiona M. Front Cell Dev Biol Cell and Developmental Biology Bardet-Biedl syndrome (BBS) is a ciliopathy with pleiotropic effects on multiple tissues, including the kidney. Here we have compared renal differentiation of iPS cells from healthy and BBS donors. High content image analysis of WT1-expressing kidney progenitors showed that cell proliferation, differentiation and cell shape were similar in healthy, BBS1, BBS2, and BBS10 mutant lines. We then examined three patient lines with BBS10 mutations in a 3D kidney organoid system. The line with the most deleterious mutation, with low BBS10 expression, expressed kidney marker genes but failed to generate 3D organoids. The other two patient lines expressed near normal levels of BBS10 mRNA and generated multiple kidney lineages within organoids when examined at day 20 of organoid differentiation. However, on prolonged culture (day 27) the proximal tubule compartment degenerated. Introducing wild type BBS10 into the most severely affected patient line restored organoid formation, whereas CRISPR-mediated generation of a truncating BBS10 mutation in a healthy line resulted in failure to generate organoids. Our findings provide a basis for further mechanistic studies of the role of BBS10 in the kidney. Frontiers Media S.A. 2023-06-02 /pmc/articles/PMC10272764/ /pubmed/37333983 http://dx.doi.org/10.3389/fcell.2023.1163825 Text en Copyright © 2023 Williams, Hurling, Munir, Harley, Machado, Cujba, Alvarez-Fallas, Danovi, Lieberam, Sancho, Beales and Watt. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Cell and Developmental Biology Williams, James Hurling, Chloe Munir, Sabrina Harley, Peter Machado, Carolina Barcellos Cujba, Ana-Maria Alvarez-Fallas, Mario Danovi, Davide Lieberam, Ivo Sancho, Rocio Beales, Philip Watt, Fiona M. Modelling renal defects in Bardet-Biedl syndrome patients using human iPS cells |
title | Modelling renal defects in Bardet-Biedl syndrome patients using human iPS cells |
title_full | Modelling renal defects in Bardet-Biedl syndrome patients using human iPS cells |
title_fullStr | Modelling renal defects in Bardet-Biedl syndrome patients using human iPS cells |
title_full_unstemmed | Modelling renal defects in Bardet-Biedl syndrome patients using human iPS cells |
title_short | Modelling renal defects in Bardet-Biedl syndrome patients using human iPS cells |
title_sort | modelling renal defects in bardet-biedl syndrome patients using human ips cells |
topic | Cell and Developmental Biology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10272764/ https://www.ncbi.nlm.nih.gov/pubmed/37333983 http://dx.doi.org/10.3389/fcell.2023.1163825 |
work_keys_str_mv | AT williamsjames modellingrenaldefectsinbardetbiedlsyndromepatientsusinghumanipscells AT hurlingchloe modellingrenaldefectsinbardetbiedlsyndromepatientsusinghumanipscells AT munirsabrina modellingrenaldefectsinbardetbiedlsyndromepatientsusinghumanipscells AT harleypeter modellingrenaldefectsinbardetbiedlsyndromepatientsusinghumanipscells AT machadocarolinabarcellos modellingrenaldefectsinbardetbiedlsyndromepatientsusinghumanipscells AT cujbaanamaria modellingrenaldefectsinbardetbiedlsyndromepatientsusinghumanipscells AT alvarezfallasmario modellingrenaldefectsinbardetbiedlsyndromepatientsusinghumanipscells AT danovidavide modellingrenaldefectsinbardetbiedlsyndromepatientsusinghumanipscells AT lieberamivo modellingrenaldefectsinbardetbiedlsyndromepatientsusinghumanipscells AT sanchorocio modellingrenaldefectsinbardetbiedlsyndromepatientsusinghumanipscells AT bealesphilip modellingrenaldefectsinbardetbiedlsyndromepatientsusinghumanipscells AT wattfionam modellingrenaldefectsinbardetbiedlsyndromepatientsusinghumanipscells |